Why the study?
Does the combination of BNP levels and noninvasive hemodynamic parameters improve the diagnosis and prognostication of congestive heart failure in men presenting to the emergency department with dyspnea?
Does the combination of BNP levels and noninvasive hemodynamic parameters improve the diagnosis and prognostication of congestive heart failure in men presenting to the emergency department with dyspnea?
The addition of noninvasive hemodynamic measurements via impedance cardiography to BNP testing in the emergency department aids in diagnosing heart failure type and predicting 90-day clinical outcomes.
Answers are grounded in this paper and cite their sources.
May support BNP plus noninvasive hemodynamics for ED dyspnea evaluation; hypothesis-generating and requires prospective validation before practice change.
This study aimed to assess whether the combination of a B-type natriuretic peptide (BNP) level with various noninvasive hemodynamic parameters can help physicians more quickly and accurately diagnose congestive heart failure and determine the type of left ventricular dysfunction present in patients presenting to the emergency department with dyspnea. Subjects were 98 men (aged 64.57+/-1.23 years) that presented to the VA San Diego Healthcare System. Hemodynamic parameters were measured using impedance cardiography, and BNP levels were quantified using a rapid immunoassay. All patients with a BNP <100 pg/mL (n=37) had no evidence of congestive heart failure 97% of the time. In those with a BNP >100 pg/mL (601+/-55 pg/mL; n=61), a cardiac index of 2.6 L/min/m2 is 65% sensitive and 88% specific in determining systolic dysfunction. In patients with a BNP >100 pg/mL, a multivariate model consisting of noninvasive hemodynamic measurements was able to predict cardiac deaths, readmissions, and emergency department visits within 90 days with 83% accuracy. The authors conclude that, in patients presenting to an emergency department with dyspnea, the addition of impedance cardiography measurements to BNP level measurements will more effectively diagnose congestive heart failure and determine both the type of heart dysfunction and the severity of illness.
No takes yet. Share an insight, caveat, or question.
Barcarse et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: